Heparin: An Old Drug with a New Paradigm
Author:
- 2 November 1979
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 206 (4418) , 528-533
Abstract
Recent studies have shown that heparin is a biochemical representative of a distinct class of compounds known as linear anionic polyelectrolytes. Members of this class are mixtures of individual highly negatively charged chains that show a wide spectrum of specific reactions with biologically active proteins. Upon administration, heparin chains enter a cellular pool and effectively prevent thrombosis by increasing the electronegative potential of the vessel wall. Anticoagulant activity is an unusual feature of a few heparin chains and appears to play a minor role in many clinical uses and in physiological and pathological responses.Keywords
This publication has 19 references indexed in Scilit:
- Glycosaminoglycans and Their Binding to Biological MacromoleculesAnnual Review of Biochemistry, 1978
- Determination of Heparin and Related Sulfated Mucopolysaccharides1977
- The Plasma Membrane Consists of Two Polar–Nonpolar–Polar LeafletsUpsala Journal of Medical Sciences, 1977
- Interaction Between Polysaccharides and Other Substances. Equilibrium ConditionsUpsala Journal of Medical Sciences, 1977
- The observation of heparin on endothelium after injectionThrombosis Research, 1976
- Polyelectrolytes, Past, Present and FuturePure and Applied Chemistry, 1976
- The mast cells in the light of new knowledge of heparin and sulfated mucopolysaccharidesGeneral Pharmacology: The Vascular System, 1975
- Chemistry and Pharmacology of HeparinJournal of Pharmaceutical Sciences, 1973
- Physiologic actions of heparin not related to blood clottingThe American Journal of Cardiology, 1964
- Heparinoide Chemie und tierexperimentelle PrüfungChemotherapy, 1961